We are live on ! Find out more
KALV

KalVista Pharmaceuticals

Delisted

KALV was delisted on the 10th of June, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
SHI
1
SV Health Investors
Massachusetts
$24.5M
RCM
2
RA Capital Management
Massachusetts
$13.7M
EAM
3
Eventide Asset Management
Massachusetts
$8.53M +$2M +191,000 +27%
IVM
4
InterWest Venture Management
California
$3.13M
IBT
5
International Biotechnology Trust
United Kingdom
$3.01M
VC
6
Vivo Capital
California
$2.85M
Millennium Management
7
Millennium Management
New York
$2.17M -$76.8K -7,336 -3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.11M -$13K -1,243 -1%
SLG
9
Stanley-Laman Group
Pennsylvania
$429K +$473K +45,221 New
Renaissance Technologies
10
Renaissance Technologies
New York
$412K -$474K -45,300 -51%
Deutsche Bank
11
Deutsche Bank
Germany
$409K -$427K -40,759 -49%
BCM
12
Bridgeway Capital Management
Texas
$389K +$429K +41,000 New
DZ Bank
13
DZ Bank
Germany
$385K +$425K +40,636 New
JP Morgan Chase
14
JP Morgan Chase
New York
$199K -$85.1K -8,133 -28%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$196K
DS
16
DRW Securities
Illinois
$142K +$31.4K +3,000 +25%
BlackRock
17
BlackRock
New York
$50K +$3.85K +368 +7%
FQ
18
First Quadrant
California
$44K -$13.1K -1,247 -21%
TRCT
19
Tower Research Capital (TRC)
New York
$12K +$4.62K +441 +53%
Federated Hermes
20
Federated Hermes
Pennsylvania
$5K +$5.27K +503 New
PCM
21
Prelude Capital Management
New York
$3K +$3.14K +300 New
Manulife (Manufacturers Life Insurance)
22
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K
UBS Group
23
UBS Group
Switzerland
$1K -$15.1K -1,446 -91%
VFA
24
Valeo Financial Advisors
Indiana
$1K
NC
25
Nexthera Capital
New York
-$1.76M -180,794 Closed